Varespladib Methyl
N/A
Report date: 2023/02/10 15:27:18
NME
Base Information
Drug NameVarespladib Methyl
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[17]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And CompanyShionogi & Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesOphirex Inc
Inactive CompaniesAnthera Pharmaceuticals Inc
Active Indications
Inactive Indications